medigraphic.com
ISSN 1561-3194 (Electronic)

2013, Number 4

<< Back Next >>

Rev Ciencias Médicas 2013; 17 (4)

Myotonic dystrophy Type I

Ramírez SP, Valladares JVE

Language: Spanish
References: 11
Page: 172-179
PDF size: 95.51 Kb.


ABSTRACT

Introduction: Steinert's Myotonic Dystrophy is a multiple-system, autosomal dominant of variable penetrance disease caused by an expansion of the cytosinethymine- guanine (CTG) triplet, in the gene which codes for myotonic dystrophy protein kinase in chromosome19q13. It is characterized by a phenomenon known as anticipation, thus its expression is greater in successive generations and it correlates with the size of expansion. From the clinical view point it is expressed by multiple-system disorders associated with a muscle-dysfunction, the most frequent characteristics are muscle weakness it progresses slowly, muscle atrophy and myotonic phenomenon.
Case report: a 52-year old patient who was visited in his home during the study that involved disabled people in Canton, Quito, the patient suffered from Steinert's Myotonic Dystrophy,the the rest members of the family were as well examined; signs and symptoms of the disease were found in three other family members.
Conclusions: the study demonstrated the non-existence of a system to perform genetic counselling in the community, which would permit the follow-up of the families and patients suffering from Steinert's Myotonic Dystrophy, this difficulty also impedes the acquisition of knowledge regarding the level of recurrence for this type of genetic disorder.


REFERENCES

  1. Zaki M, Boyd PA, Impey L, Roberts A, Chamberlain P. Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome. Ultrasound Obstet Gynecol. 2007; 29: 284-8.

  2. De León MB, Cisneros B. Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms. J Neurosci Res. 2008; 86: 18-26.

  3. Muraoka H, Negoro N, Terasaki F et al. Re-entry circuit in ventricular tachycardia due to focal fatty-fibrosis in a patient with myotonic dystrophy. Intern Med. 2005; 44:129-135.

  4. Huson S. Myotonic dystrophy-time to improve patient care and prepare for pathogenesis based treatments. European Journal of Human Genetics. 2005; 13(12):1312-1312.

  5. Martorell L, Cobo AM, Baiget M, Naud M, Poza, Parra J. Prenatal diagnosis in myotonic dystrophy type 1. Thirteen years of experience: implications for reproductive counseling in DM1 families. Prenatal Diagnosis. 2007; 27: 68-72.

  6. Klein A, Clement E, Mercuri E, Muntoni F. Differential diagnosis of congenital muscular dystrophies. Eur J Paediatr Neurol. 2008; 12: 371-7

  7. Guimarães AS, Suazo GI, Nagahashi Marie SK. Fenómeno miotónico orofacial en pacientes con distrofia miotónica de Steinert. Avances en Odontoestomatología. 2010 May-Jun; 26 (3):139-142

  8. Schara U, Schoser BG. Myotonic dystrophies type 1 and 2: a summary on current aspects. Semin Pediatr Neurol. 2006 13: 71-9.

  9. Castel A.L., Cleary J.D. and Pearson C.E. Repeat instability as the basis for human diseases and as a potential target for therapy. Nat Rev Mol Cell Biol. 2010; 11, 165-170.

  10. Sayed AT, Moran PA. Myotonic dystrophy in pregnancy `a salutary tale'. J Obstet Gynaecol 2006; 26(3): 258-60.

  11. Argov Z, de Visser M. What we do not know about pregnancy in hereditary neuromuscular disorders. Neuromuscular Disorders 2009; 19(10): 675-9.




2020     |     www.medigraphic.com